Baricitinib vs Nivolumab

## Baricitinib vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Baricitinib** and **Nivolumab**.

## Mechanism of Action

**Baricitinib**: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Baricitinib — 12 hours; Nivolumab — 27 days.

## Chemical Properties

**Molecular Formula**: Baricitinib — C16H17N7O2S; Nivolumab — N/A.

**Molecular Weight**: Baricitinib — 371.4170 g/mol; Nivolumab — N/A.

**Type**: Baricitinib — Small molecule; Nivolumab — Antibody.